March Uptick Suggests Reversal For Olainfarm
While ‘Substantial Results’ Seen From Distribution Alliance In Ukraine
Olainfarm says a change in its strategy has delivered an increase in sales March despite an overall decline in the first quarter of 2020. Turnover in Ukraine shot up as a result of a new distribution alliance.
You may also be interested in...
Coronavirus-induced stockpiling and advanced prescribing of medicines has resulted in generics companies across the world registering unprecedented growth during the first quarter of 2020. However, many companies predict sales will level off again in the next quarter and beyond. And as demand fluctuates following the COVID-19 outbreak, companies have started taking precautionary measures to avoid supply-chain disruptions.
ANI Pharmaceuticals has finally delivered its long-awaited launch of purified Cortrophin Gel (repository corticotropin injection) in the US, accompanying the launch with its ‘Cortrophin In Your Corner’ dedicated program to increase access and provide reimbursement support.
To extend its representation in Europe, IGBA has welcomed the generic and biosimilar drug association of Serbia and Montenegro – Genezis – to the global off-patent industry body.